Current approaches to therapy of ALK-positive non-small cell lung cancer

This article analyzes approaches of the treatment of ALK-positive non-small cell lung cancer (NSCLC). Despite the relatively small percentage of patients with ALK-gene rearrangements, identification of this mutation is very important. The most effective treatment for patients with ALK translocation...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: К. К. Laktionov, S Yu. Kruteleva, Е. V. Reutova
Aineistotyyppi: Artigo
Kieli:Russo
Julkaistu: Remedium Group LLC 2021-06-01
Sarja:Медицинский совет
Aiheet:
non-small cell lung cancer
alk translocation
alk inhibitors
resistance
crizotinib
lorlatinib
ceretinib
alectinib
brigatinib
Linkit:https://www.med-sovet.pro/jour/article/view/6207
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia